MedTrace Logo

Piperacillin/Tazobactam for Bacteremia With Organisms Producing Chromosomally-Encoded AmpC Beta-Lactamase

NCT00414193 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2018-06-14

No results posted yet for this study

Summary

Nosocomial bloodstream infections are important causes of morbidity and mortality caused by AmpC beta-lactamase-producing Enterobacteriaceae. The information collected will optimize the management of patients with nosocomial bloodstream infections.

Conditions

  • Bacteremia
  • AmpC Beta-lactamase

Sponsors & Collaborators

  • Japan Health Sciences Foundation

    collaborator UNKNOWN

  • University of Pittsburgh

    lead OTHER

Principal Investigators

  • David L Paterson, MD · University of Pitttsburgh

  • Yohei Doi, MD · University of Pittsburgh

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-02-28
Primary Completion
2017-12-31
Completion
2017-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00414193 on ClinicalTrials.gov